NIAGEN BIOSCIENCE, INC. Interest Income (Expense), Net
NIAGEN BIOSCIENCE, INC. (NAGE) reported Interest Income (Expense), Net of $239.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2024-05-08
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for the quarter ending 2024-03-31 was $239.00K, a 262.12% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for the quarter ending 2023-12-31 was $282.00K, a 984.62% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for the quarter ending 2023-09-30 was $188.00K.
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for the quarter ending 2023-06-30 was $125.00K.
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for fiscal 2023 was $661.00K, a 21933.33% increase from fiscal 2022.
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for fiscal 2022 was $3.00K.
- NIAGEN BIOSCIENCE, INC. interest income (expense), net for fiscal 2021 was -$55.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2024-03-31 | $239.00K 10-Q · filed 2024-05-08 | $521.00K derived: sum of 2 quarters · filed 2024-05-08 | $709.00K derived: sum of 3 quarters · filed 2024-05-08 | $834.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $470.00K derived: sum of 2 quarters · filed 2024-03-06 | $595.00K derived: sum of 3 quarters · filed 2024-03-06 | $661.00K 10-K · filed 2024-03-06 |
| 2023-09-30 | $188.00K 10-Q · filed 2023-11-08 | $313.00K derived: sum of 2 quarters · filed 2023-11-08 | $379.00K 10-Q · filed 2023-11-08 | $405.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $125.00K 10-Q · filed 2023-08-09 | $191.00K 10-Q · filed 2023-08-09 | $217.00K derived: sum of 3 quarters · filed 2024-05-08 | $212.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $66.00K 10-Q · filed 2024-05-08 | $92.00K derived: sum of 2 quarters · filed 2024-05-08 | $87.00K derived: sum of 3 quarters · filed 2024-05-08 | $77.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $21.00K derived: sum of 2 quarters · filed 2024-03-06 | $11.00K derived: sum of 3 quarters · filed 2024-03-06 | $3.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | -$5.00K 10-Q · filed 2023-11-08 | -$15.00K derived: sum of 2 quarters · filed 2023-11-08 | -$23.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -$10.00K 10-Q · filed 2023-08-09 | -$18.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$8.00K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$55.00K 10-K · filed 2023-03-08 | |||
| 2020-03-31 | -$12.00K 10-Q · filed 2020-05-18 | |||
| 2019-03-31 | $35.00K 10-Q · filed 2020-05-18 | |||
| 2018-03-31 | -$44.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |